Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Région de Kantō150
Naoki Yamamoto15
Région de Kantō Sauf Naoki Yamamoto" 138
Naoki Yamamoto Sauf Région de Kantō" 3
Région de Kantō Et Naoki Yamamoto 12
Région de Kantō Ou Naoki Yamamoto 153
Corpus10380
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
002114 Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida ; Masaya Fukushi ; Keina Yamaguchi ; Yusuke Matsuoka ; Takashi Ishihara ; Masayoshi Tsukahara ; Seisuke Hatakeyama ; Norikazu Itoh ; Aki Morisawa ; Yoshiyuki Yoshinaka ; Naoki Yamamoto ; Zhang Lianfeng ; Qin Chuan ; Teruo Kirikae ; Takehiko SasazukiFully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model.
002374 Tohru Miyoshi-Akiyama [Japon] ; Isao Ishida [Japon] ; Masaya Fukushi [Japon] ; Keina Yamaguchi [Japon] ; Yusuke Matsuoka [Japon] ; Takashi Ishihara [Japon] ; Masayoshi Tsukahara [Japon] ; Seisuke Hatakeyama [Japon] ; Norikazu Itoh [Japon] ; Aki Morisawa [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Naoki Yamamoto [Japon] ; ZHANG LIANFENG [République populaire de Chine] ; QIN CHUAN [République populaire de Chine] ; Teruo Kirikae [Japon] ; Takehiko Sasazuki [Japon]Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
002431 Shiori Haga [Japon] ; Noriyo Nagata ; Tadashi Okamura ; Norio Yamamoto ; Tetsutaro Sata ; Naoki Yamamoto ; Takehiko Sasazuki ; Yukihito IshizakaTACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
002917 Shiori Haga [Japon] ; Noriyo Nagata [Japon] ; Tadashi Okamura [Japon] ; Norio Yamamoto [Japon] ; Tetsutaro Sata [Japon] ; Naoki Yamamoto [Japon] ; Takehiko Sasazuki [Japon] ; Yukihito Ishizaka [Japon]TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds
003075 Shiori Haga [Japon] ; Norio Yamamoto ; Chikako Nakai-Murakami ; Yoshiaki Osawa ; Kenzo Tokunaga ; Tetsutaro Sata ; Naoki Yamamoto ; Takehiko Sasazuki ; Yukihito IshizakaModulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.
003103 Makoto Ujike [Japon] ; Hiroki Nishikawa ; Akira Otaka ; Naoki Yamamoto ; Norio Yamamoto ; Masao Matsuoka ; Eiichi Kodama ; Nobutaka Fujii ; Fumihiro TaguchiHeptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway.
003519 Yu-Ya Mitsuki [Japon] ; Kazuo Ohnishi [Japon] ; Hirotaka Takagi [Japon] ; Masamichi Oshima [Japon] ; Takuya Yamamoto [Japon] ; Fuminori Mizukoshi [Japon] ; Kazutaka Terahara [Japon] ; Kazuo Kobayashi [Japon] ; Naoki Yamamoto [Japon] ; Shoji Yamaoka [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]A single amino acid substitution in the Sl and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV
003B76 Masaji Okada [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Yoko Kita [Japon] ; Noriko Kanamaru [Japon] ; Yasuko Nishida [Japon] ; Yoshie Tsunai [Japon] ; Ruriko Inoue [Japon] ; Hitoshi Nakatani [Japon] ; Reiko Fukamizu [Japon] ; Yumi Namie [Japon] ; Junko Yamada [Japon] ; Kyoko Takao [Japon] ; Ritsuko Asai [Japon] ; Ryoko Asaki [Japon] ; Tetsuo Kase [Japon] ; Yuji Takemoto [Japon] ; Shigeto Yoshida [Japon] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models
004812 Yu Zhong [Japon] ; Yoshiyuki Yoshinaka ; Tadahiro Takeda ; Noriko Shimizu ; Sayaka Yoshizaki ; Yoshio Inagaki ; Shinobu Matsuda ; Gisho Honda ; Nobutaka Fujii ; Naoki YamamotoHighly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton.
004D45 Masaji Okada [Japon] ; Yuji Takemoto [Japon] ; Yoshinobu Okuno [Japon] ; Satomi Hashimoto [Japon] ; Shigeto Yoshida [Japon] ; Yukari Fukunaga [Japon] ; Takao Tanaka [Japon] ; Yoko Kita [Japon] ; Sachiko Kuwayama [Japon] ; Yumiko Muraki [Japon] ; Noriko Kanamaru [Japon] ; Hiroko Takai [Japon] ; Chika Okada [Japon] ; Yayoi Sakaguchi [Japon] ; Izumi Furukawa [Japon] ; Kyoko Yamada [Japon] ; Makoto Matsumoto [Japon] ; Tetsuo Kase [Japon] ; Daphne E. Demello [États-Unis] ; J. S. M. Peiris [Hong Kong] ; Pei-Jer Chen [Taïwan] ; Naoki Yamamoto [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tatsuji Nomura [Japon] ; Isao Ishida [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Mitsunori Sakatani [Japon]The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice
004E20 YU ZHONG [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Tadahiro Takeda [Japon] ; Noriko Shimizu [Japon] ; Sayaka Yoshizaki [Japon] ; Yoshio Inagaki [Japon] ; Shinobu Matsuda [Japon] ; Gisho Honda [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]Highly potent anti-HIV-1 activity isolated from fermented Polygonum tinctorium Aiton
005332 Norio Yamamoto [Japon] ; Rongge Yang [Japon] ; Yoshiyuki Yoshinaka [Japon] ; Shinji Amari [Japon] ; Tatsuya Nakano [Japon] ; Jindrich Cinatl [Allemagne] ; Holger Rabenau [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; Gerhard Hunsmann [Allemagne] ; Akira Otaka [Japon] ; Hirokazu Tamamura [Japon] ; Nobutaka Fujii [Japon] ; Naoki Yamamoto [Japon]HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021